Suppr超能文献

鼻腔内给予酮咯酸用于成人急诊科急性疼痛。

Intranasal Ketorolac for Acute Pain in Adult Emergency Department Patients.

机构信息

Emergency Services Institute, Cleveland Clinic, Cleveland, OH, USA.

Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

出版信息

West J Nurs Res. 2022 Nov;44(11):1047-1056. doi: 10.1177/01939459211030336. Epub 2021 Aug 7.

Abstract

Pain is a common complaint in the emergency department. An alternative to opioids is desirable. Oral medications are not feasible with gastrointestinal disorders or NPO. Intravenous medications require skill and time. Intravenous/intramuscular medications are painful with potential needlestick injury. Intranasal medications have rapid onset, easy administration, do not need skilled providers, and no risk of needlestick injury. A total of 28 adults with acute pain (numeric rating scale ≥ 4) received intranasal ketorolac. Numeric rating scale decreased in all: 32% complete pain relief, median (interquartile range) decrease -5 (-6.8 to -4) ( < .001). Pain relief onset was median [interquartile range] 5 (2.3, 15.0) min. Vital signs remained normal. There were no nasal mucosal changes, no complications. Minor side effects, mostly nasal burning, in 43%, resolved within 5 min. Patients and nurses were satisfied with intranasal ketorolac, and would use it again. Intranasal ketorolac had a rapid onset, was effective, safe, well tolerated with minor side effects that resolved quickly.

摘要

疼痛是急诊科常见的主诉。需要一种替代阿片类药物的方法。对于胃肠道疾病或禁食的患者,口服药物不可行。静脉内药物需要技巧和时间。静脉内/肌内药物注射疼痛,且有潜在的针刺伤风险。鼻内药物起效迅速,给药方便,不需要熟练的医护人员,也没有针刺伤的风险。总共 28 名急性疼痛(数字评分量表≥4)的成年人接受了鼻内酮咯酸治疗。所有患者的数字评分量表均有所下降:32%的患者完全缓解疼痛,中位数(四分位间距)下降-5(-6.8 至-4)( < .001)。疼痛缓解的中位时间[四分位间距]为 5(2.3,15.0)分钟。生命体征保持正常。无鼻黏膜变化,无并发症。43%的患者出现轻微的副作用,主要为鼻烧灼感,5 分钟内缓解。患者和护士对鼻内酮咯酸均满意,并表示愿意再次使用。鼻内酮咯酸起效迅速,有效,安全,耐受性好,副作用轻微且迅速缓解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验